Premas brings bringing synthetic biology to India

Twist Bioscience Corporation, a San Francisco company enabling customers to succeed through its offering of high-quality synthetic DNA, has selected Premas Lifesciences for India which is part of its expansion in Asia Pacific.

This is for strategic distribution partners for synthetic DNA (genes, gene fragment, oligo pool product lines) as well as the exome and custom target enrichment product suite for next-generation sequencing.

“The synthetic biology and next-generation sequencing markets are growing rapidly in Asia Pacific, and we are now poised to serve customers in Japan, Korea, India and Hong Kong,” said Emily M. Leproust, Ph.D., CEO of Twist Bioscience.

“Building on our solid foundation in the United States and Europe, we are extending our global footprint by leveraging selected distributors with strong commercial presence and deep ties to our potential customers in these important geographies,” said Leproust in a statement on 18 April 2018.

Premas Lifesciences is a knowledge driven boutique partner for a range of specialized technologies in the field of life science, genomics, cell biology, bio banking and other related applications. The company prides itself in establishing concepts in the nascent markets which became industry norm.

“Partnering with rapidly-growing companies to expand their reach within India is our specialty at Premas Lifesciences, and we look forward to bringing the power of synthetic biology to India to fuel new and differentiated research in a timely fashion,” said Praveen Gupta, managing director of Premas.

Related to this expansion, Twist Bioscience has entered into distribution agreements with Recenttec K.K. in Japan; DNA Link and its subsidiary LnCBio Inc. in Korea; and BioArrow Technology Limited in Hong Kong and Macau.

Each organization will be responsible for distributing Twist Bioscience’s products in their respective geographies. fii-news.com